Dorn A, Stoffel R, Matile H, Bubendorf A, Ridley R G
Pharma Division, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Nature. 1995 Mar 16;374(6519):269-71. doi: 10.1038/374269a0.
Malarial parasites growing inside erythrocytes digest up to 80% of the host cell's haemoglobin within a lysosomal organelle, the digestive vacuole. They sequester the potentially toxic haem (Fe (II) protohaematoporphyrin) that is released during this process into an insoluble pigment called haemozoin, which consists of polymerized Fe (III) protohaematoporphyrin subunits. We have studied this process of haem polymerization, which was previously reported to be enzyme-mediated and the target of the quinoline antimalarial drugs chloroquine and quinine. Here we show that, rather than being enzyme-mediated, haem polymerization is actually a chemical process, dependent only on the presence of haem-derived material associated with haemozoin and not on protein. This discovery does not invalidate haem polymerization as a target for drug intervention and the mechanism by which haemozoin formation is initiated is still not understood, but our view of this process and of the action of choroquine must be reconsidered.
在红细胞内生长的疟原虫,会在一种溶酶体细胞器即消化泡内,消化掉宿主细胞高达80%的血红蛋白。它们将在此过程中释放出的具有潜在毒性的血红素(亚铁原卟啉)隔离到一种名为疟色素的不溶性色素中,疟色素由聚合的高铁原卟啉亚基组成。我们研究了血红素聚合的这一过程,此前有报道称该过程是由酶介导的,并且是喹啉类抗疟药物氯喹和奎宁的作用靶点。在此我们表明,血红素聚合实际上是一个化学过程而非由酶介导,它仅取决于与疟色素相关的血红素衍生物质的存在,而不依赖于蛋白质。这一发现并未使血红素聚合作为药物干预靶点失去效力,并且疟色素形成的起始机制仍不为人所知,但我们对这一过程以及氯喹作用的看法必须重新审视。